Cucurbitacin B

Cucurbitacin b is a lipid of Sterol Lipids (ST) class. Cucurbitacin b is associated with abnormalities such as Morphologically altered structure. The involved functions are known as Signal Transduction, Apoptosis, Cell Cycle Arrest, Cell Cycle and Negative Regulation of Mitosis. Cucurbitacin b often locates in Mediastinum and Pseudopodia. The associated genes with Cucurbitacin B are STAT5A gene, JAK2 gene, STAT3 gene, CDKN1A gene and BCL2L1 gene. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of Cucurbitacin B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Cucurbitacin B?

Cucurbitacin B is suspected in Morphologically altered structure and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Cucurbitacin B

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with Cucurbitacin B

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Cucurbitacin B through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Cucurbitacin B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Cucurbitacin B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Cucurbitacin B?

There are no associated biomedical information in the current reference collection.

What genes are associated with Cucurbitacin B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Cucurbitacin B?

Xenograft Model

Xenograft Model are used in the study 'Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.' (Thoennissen NH et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Cucurbitacin B

Download all related citations
Per page 10 20 50 100 | Total 105
Authors Title Published Journal PubMed Link
Hua S et al. Protective Effects of Cucurbitacin B on Acute Lung Injury Induced by Sepsis in Rats. 2017 Med. Sci. Monit. pmid:28315572
Kim SH et al. Doxorubicin has a synergistic cytotoxicity with cucurbitacin B in anaplastic thyroid carcinoma cells. 2017 Tumour Biol. pmid:28218042
Cai F et al. Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/adriamycin cells. 2016 Oncol. Rep. pmid:27350399
Niu Y et al. PTEN Activation by DNA Damage Induces Protective Autophagy in Response to Cucurbitacin B in Hepatocellular Carcinoma Cells. 2016 Oxid Med Cell Longev pmid:28042385
Shukla S et al. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis. 2016 Sci Rep pmid:26905250
Shukla S et al. Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis. 2015 Cancer Prev Res (Phila) pmid:25813524
Silva IT et al. In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B. 2015 PLoS ONE pmid:25674792
Lv Q et al. Application of spray granulation for conversion of mixed phospholipid-bile salt micelles to dry powder form: influence of drug hydrophobicity on nanoparticle reagglomeration. 2014 Int J Nanomedicine pmid:24531119
Husen A and Siddiqi KS Carbon and fullerene nanomaterials in plant system. 2014 J Nanobiotechnology pmid:24766786
Guo J et al. Cucurbitacin B induced ATM-mediated DNA damage causes G2/M cell cycle arrest in a ROS-dependent manner. 2014 PLoS ONE pmid:24505404
Gao Y et al. Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth. 2014 Cancer Lett. pmid:24690568
Seo CR et al. Cucurbitacin B and cucurbitacin I suppress adipocyte differentiation through inhibition of STAT3 signaling. 2014 Food Chem. Toxicol. pmid:24316209
Ma J et al. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α. 2014 Eur. J. Pharmacol. pmid:24333213
Yu C et al. [Preparation and characterization of cucurbitacin B sodium deoxycholate/phospholipid-mixed oral fast dissolving film and antitumor activity study]. 2014 Zhongguo Zhong Yao Za Zhi pmid:25282885
Shang Y et al. Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN. 2014 Eur Rev Med Pharmacol Sci pmid:25487942
Zhang M et al. Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition in A549 lung cancer cells. 2014 Mol Med Rep pmid:25242136
Gupta P and Srivastava SK Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression. 2014 Oncotarget pmid:24729020
Zhang YT et al. VASP activation via the Gα13/RhoA/PKA pathway mediates cucurbitacin-B-induced actin aggregation and cofilin-actin rod formation. 2014 PLoS ONE pmid:24691407
Kole C et al. Nanobiotechnology can boost crop production and quality: first evidence from increased plant biomass, fruit yield and phytomedicine content in bitter melon (Momordica charantia). 2013 BMC Biotechnol. pmid:23622112
Hu H et al. Preparation, characterization, cellular uptake and evaluation in vivo of solid lipid nanoparticles loaded with cucurbitacin B. 2013 Drug Dev Ind Pharm pmid:22794139
Duportets L et al. Steroid hormone signaling is involved in the age-dependent behavioral response to sex pheromone in the adult male moth Agrotis ipsilon. 2013 Gen. Comp. Endocrinol. pmid:23474331
Promkan M et al. The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells. 2013 PLoS ONE pmid:23393598
Kausar H et al. Cucurbitacin B potently suppresses non-small-cell lung cancer growth: identification of intracellular thiols as critical targets. 2013 Cancer Lett. pmid:23340170
Jianbo G et al. The anti-melanoma efficiency of the intratumoral injection of cucurbitacin-loaded sustained-release carriers: a PLGA particle system. 2013 J Pharm Sci pmid:23729371
Aribi A et al. The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer. 2013 Int. J. Cancer pmid:23165325
Dakeng S et al. Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus. 2012 J. Cell. Biochem. pmid:21866566
Lu P et al. Cucurbitacin B regulates immature myeloid cell differentiation and enhances antitumor immunity in patients with lung cancer. 2012 Cancer Biother. Radiopharm. pmid:22746287
Lang KL et al. Synthesis and cytotoxic activity evaluation of dihydrocucurbitacin B and cucurbitacin B derivatives. 2012 Bioorg. Med. Chem. pmid:22472043
Zhang T et al. Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent apoptosis. 2012 Autophagy pmid:22441021
Zhu JS et al. Cucurbitacin B induces cell cycle arrest, apoptosis and autophagy associated with G actin reduction and persistent activation of cofilin in Jurkat cells. 2012 Pharmacology pmid:22699368
Duangmano S et al. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation. 2012 BMC Complement Altern Med pmid:23062075
Zhang Y et al. Cucurbitacin B induces rapid depletion of the G-actin pool through reactive oxygen species-dependent actin aggregation in melanoma cells. 2011 Acta Biochim. Biophys. Sin. (Shanghai) pmid:21642275
Ouyang D et al. Histone deacetylase inhibitor valproic acid sensitizes B16F10 melanoma cells to cucurbitacin B treatment. 2011 Acta Biochim. Biophys. Sin. (Shanghai) pmid:21628505
Jin HR et al. Cucurbitacin B suppresses the transactivation activity of RelA/p65. 2011 J. Cell. Biochem. pmid:21344491
Wei Y et al. [Studies on chemical constituents in roots of Helicteres angustifolia]. 2011 Zhongguo Zhong Yao Za Zhi pmid:21842648
Lee DH et al. Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma. 2011 Cancer Lett. pmid:21440986
Jung ME and Lui RM Studies toward the total syntheses of cucurbitacins B and D. 2010 J. Org. Chem. pmid:20873743
Chen W et al. Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines. 2010 Int. J. Oncol. pmid:20664943
Chan KT et al. Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562. 2010 Cancer Lett. pmid:19700240
Nakashima S et al. Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells. 2010 Bioorg. Med. Chem. Lett. pmid:20347305
Yasuda S et al. Cucurbitacin B induces G2 arrest and apoptosis via a reactive oxygen species-dependent mechanism in human colon adenocarcinoma SW480 cells. 2010 Mol Nutr Food Res pmid:19937855
Liu T et al. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin. 2010 Eur. J. Pharmacol. pmid:20483353
Dat NT et al. An isoaurone and other constituents from Trichosanthes kirilowii seeds inhibit hypoxia-inducible factor-1 and nuclear factor-kappaB. 2010 J. Nat. Prod. pmid:20469887
Iwanski GB et al. Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. 2010 Br. J. Pharmacol. pmid:20590594
Zhang M et al. Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling. 2010 Pancreas pmid:20182390
Wang W et al. Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability. 2010 Drug Deliv pmid:20148709
Duangmano S et al. Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle. 2010 Int J Mol Sci pmid:21614210
Chen C et al. Cucurbitane-type triterpenoids from the stems of Cucumis melo. 2009 J. Nat. Prod. pmid:19348465
Kongtun S et al. Cytotoxic properties of root extract and fruit juice of Trichosanthes cucumerina. 2009 Planta Med. pmid:19288406
Zhang M et al. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B. 2009 Cancer Chemother. Pharmacol. pmid:18521604